151 related articles for article (PubMed ID: 556944)
1. Magnetic resonance studies of the binding site interactions between phosphorylcholine and specific mouse myeloma immunoglobulin.
Goetze AM; Richards JH
Biochemistry; 1977 Jan; 16(2):228-32. PubMed ID: 556944
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relations in phosphorylcholine-binding mouse myeloma proteins.
Goetze AM; Richards JH
Proc Natl Acad Sci U S A; 1977 May; 74(5):2109-12. PubMed ID: 405672
[TBL] [Abstract][Full Text] [Related]
3. A combined proton and phosphorus-31 nuclear magnetic resonance investigation of the combining site of M603, a phosphocholine-binding myeloma protein.
Gettins P; Pótter M; Leatherbarrow RJ; Dwek RA
Biochemistry; 1982 Sep; 21(20):4927-31. PubMed ID: 6291593
[TBL] [Abstract][Full Text] [Related]
4. Investigation of hapten-antibody interactions in McPC603 by 1 H and 31 P NMR spectroscopy.
Gettins P; Potter M; Rudikoff S; Dwek RA
FEBS Lett; 1977 Dec; 84(1):87-91. PubMed ID: 590531
[No Abstract] [Full Text] [Related]
5. Molecular studies of subspecificity differences among phosphorylcholine-binding mouse myeloma antibodies using 31P nuclear magnetic resonance.
Goetze AM; Richards JH
Biochemistry; 1978 May; 17(9):1733-9. PubMed ID: 26385
[No Abstract] [Full Text] [Related]
6. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site.
Segal DM; Padlan EA; Cohen GH; Rudikoff S; Potter M; Davies DR
Proc Natl Acad Sci U S A; 1974 Nov; 71(11):4298-302. PubMed ID: 4530984
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance studies of the binding site interactions between 19F-labeled nitrophenyl haptens and specific mouse myeloma immunoglobulin MOPC-315.
Kooistra DA; Richards JH
Biochemistry; 1978 Jan; 17(2):345-51. PubMed ID: 619995
[TBL] [Abstract][Full Text] [Related]
8. The circular dichroism of phosphocholine-specific mouse hybridoma and myeloma proteins: unusual properties of the hybridoma protein 101.6G6.
Young NM; Williams RE; Claflin JL
Mol Immunol; 1985 Mar; 22(3):305-11. PubMed ID: 2582246
[TBL] [Abstract][Full Text] [Related]
9. Structure of a phosphorycholine-binding mouse myeloma Fab.
Padlan EA; Segal DM; Cohen GH; Davies DR; Rudikoff S; Potter M
Transplant Proc; 1975 Jun; 7(2):219-22. PubMed ID: 48300
[No Abstract] [Full Text] [Related]
10. Immune response to phosphorylcholine. I. Characterization of the epitope-specific antibody.
Kluskens L; Lee W; Köhler H
Eur J Immunol; 1976 Jul; 5(7):489-96. PubMed ID: 61872
[TBL] [Abstract][Full Text] [Related]
11. Antibody--hapten interactions in solution.
Dwek RA; Jones R; Marsh D; McLaughlin AC; Press EM; Price NC; White AI
Philos Trans R Soc Lond B Biol Sci; 1975 Nov; 272(915):53-74. PubMed ID: 1818
[TBL] [Abstract][Full Text] [Related]
12. Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.
Wain-Hobson S; Dower SK; Gettins P; Givol D; McLaughlin AC; Pecht I; Sunderland CA; Dwek RA
Biochem J; 1977 Aug; 165(2):227-35. PubMed ID: 921746
[TBL] [Abstract][Full Text] [Related]
13. Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis.
Rudikoff S; Potter M; Segal DM; Padlan EA; Davies DR
Proc Natl Acad Sci U S A; 1972 Dec; 69(12):3689-92. PubMed ID: 4566456
[TBL] [Abstract][Full Text] [Related]
14. Kappa chain structure from a crystallized murine Fab': role of joining segment in hapten binding.
Rudikoff S; Satow Y; Padlan E; Davies D; Potter M
Mol Immunol; 1981 Aug; 18(8):705-11. PubMed ID: 6796825
[No Abstract] [Full Text] [Related]
15. The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution.
Suh SW; Bhat TN; Navia MA; Cohen GH; Rao DN; Rudikoff S; Davies DR
Proteins; 1986 Sep; 1(1):74-80. PubMed ID: 3449853
[TBL] [Abstract][Full Text] [Related]
16. Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins.
Rudikoff S; Potter M
Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2109-12. PubMed ID: 819932
[TBL] [Abstract][Full Text] [Related]
17. Contributions by ionic and steric features of ligands to their binding with phosphorylcholine-specific immunoglobulin IgA H-8 as determined by fluorescence spectroscopy.
Bennett LG; Glaudemans CP
Biochemistry; 1979 Jul; 18(15):3337-42. PubMed ID: 465473
[TBL] [Abstract][Full Text] [Related]
18. Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.
Dwek RA; Givol D; Jones R; McLaughlin AC; Wain-Hobson S; White AI; Wright C
Biochem J; 1976 Apr; 155(1):37-53. PubMed ID: 7239
[TBL] [Abstract][Full Text] [Related]
19. The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315.
Dower SK; Wain-Hobson S; Gettins P; Givol D; Jackson WR; Perkins SJ; Sunderland CA; Sutton BJ; Wright CE; Dwek RA
Biochem J; 1977 Aug; 165(2):207-23. PubMed ID: 921744
[TBL] [Abstract][Full Text] [Related]
20. Relation between structure and specificity of antibodies: nuclear magnetic resonance study of binding fluorine-19 labeled nitrophenyl haptens to myeloma immunoglobulins M315, M460, and X25.
Hardy RR; Richards JH
Biochemistry; 1978 Sep; 17(18):3866-71. PubMed ID: 698204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
